Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Industry Trends

Clinical Trial Trends

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Disease Area Trends

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Recent Tweets

Ozmosi Follow

BioPharma/Biotech Intel. Daily $XBI $XPH Market Movers Database: https://t.co/IBOqbSoYuc Clinical trial tools: https://t.co/A77u9Q84Dc https://t.co/AQERg9nHrb

OzmosiHealth
ozmosihealth Ozmosi @ozmosihealth ·
16h

$CRMD CorMedix Inc. reveals that CMS has awarded TDAPA to DefenCath.

More Info: https://pryzm.ozmosi.com/product/2121 $XBI $IBB $XPH $PPH

Reply on Twitter 1781303475550470643 Retweet on Twitter 1781303475550470643 Like on Twitter 1781303475550470643 Twitter 1781303475550470643
ozmosihealth Ozmosi @ozmosihealth ·
17h

$OCGN Ocugen completes dosing of subjects with Geographic Atrophy in Phase 1/2 ArMaDa trial of OCU410 gene therapy modifier.

More Info: https://pryzm.ozmosi.com/product/27030 $XBI $IBB $XPH $PPH

Reply on Twitter 1781288418498208177 Retweet on Twitter 1781288418498208177 4 Like on Twitter 1781288418498208177 10 Twitter 1781288418498208177
ozmosihealth Ozmosi @ozmosihealth ·
17h

FDA approves GenFleet Therapeutics' GFH925 for Phase III study on treating metastatic colorectal cancer with KRAS G12C inhibitor monotherapy.

More Info: https://pryzm.ozmosi.com/product/26990 $XBI $IBB $XPH $PPH

Reply on Twitter 1781288411246350436 Retweet on Twitter 1781288411246350436 Like on Twitter 1781288411246350436 Twitter 1781288411246350436
ozmosihealth Ozmosi @ozmosihealth ·
17h

$MRK Health Canada has approved KEYTRUDA® for adult patients with advanced gastric or GEJ adenocarcinoma in combination with chemotherapy containing fluoropyrimidine and platinum.

More Info: https://pryzm.ozmosi.com/product/6714 $XBI $IBB $XPH $PPH

Reply on Twitter 1781288403977531694 Retweet on Twitter 1781288403977531694 Like on Twitter 1781288403977531694 Twitter 1781288403977531694
Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

Get in Touch

info@ozmosi.com
(732) 701-7807

600 Warren Ave,
Spring Lake, NJ 07762